The MIPACT study is a prospective cohort study designed to integrate multiple sources of digital data to better understand clinical phenotypes. Participants were recruited from Michigan Medicine and the surrounding communities and provided with an Apple Watch series 3 or 4 and an Omron Evolv Wireless Blood Pressure Monitor. Participants consented to provide access to parts of their electronic medical record and to provide a blood sample for laboratory and genetic analyses. Participants were asked to perform regular tasks including guided breathing, BP monitoring, and quarterly survey completion. The study was funded in part by Apple, Inc and performed in partnership with Michigan Medicine.

Displayed on the MIPACT Cohort Identification Toolkit you will find information from the first 90-days of participation for nearly 7,000 participants from the University of Michigan. Normative heart rate, blood pressure, Apple Watch step count, and Apple Watch distance walking/running is available for these participants. Clinical conditions for participants were defined using the ICD-9 and ICD-10 codes below.